Bladder Prolapse (Cystocele): Evolving Treatment Approaches, Emerging Technologies, and Market Trends
Bladder Prolapse, medically termed cystocele, is a common pelvic floor disorder in which the bladder descends into the vaginal canal due to weakening of the supporting pelvic muscles and connective tissues. It predominantly affects women, especially after childbirth, menopause, or pelvic surgery. With an aging global female population and rising awareness of pelvic health, bladder prolapse has become an important focus area in urogynecology, driving innovation in treatment modalities and healthcare markets.
Understanding Bladder Prolapse (Cystocele)
Cystocele occurs when the pelvic floor muscles and ligaments that hold the bladder in its normal position become stretched or damaged. Risk factors include vaginal childbirth, chronic coughing, obesity, heavy lifting, and estrogen deficiency after menopause. Symptoms range from mild pelvic pressure and urinary frequency to severe discomfort, urinary incontinence, and difficulty emptying the bladder. The condition is generally classified into mild, moderate, or severe stages based on the extent of bladder descent.


